BioTech Medics, Inc.
BioTech Medics, Inc. (BMCS) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
bmcs · pe ratio · data through Dec 31, 2024
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for BioTech Medics, Inc. (BMCS) measures how much investors pay for each dollar of the company's trailing earnings. BMCS's current PE ratio of 1.24x is calculated by dividing its stock price of $0.00 by its TTM earnings per share of $0.00.
Source: FMP · /ratios-ttm · /analyst-estimates · 2024-12-31
PE Ratio History
2015 – 2024 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
BioTech Medics, Inc.You BMCS | $0M | 1.24x | — | $0.00 |
 Bionoid Pharma, Inc. BINP | $2M | N/A | — | -$0.01 |
 Body and Mind Inc. BMMJ | $0M | N/A | — | -$0.16 |
 CTT Pharmaceutical Holdings, Inc. CTTH | $2M | N/A | — | -$0.00 |
 Endexx Corporation EDXC | $0M | N/A | — | -$0.01 |
 Galexxy Holdings, Inc. GXXY | $0M | N/A | — | -$0.01 |
 Herborium Group, Inc. HBRM | $1M | N/A | — | -$0.00 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2024-12-31Latest FY2024 | — | $-0.00 | — | |
2023-12-31 FY2023 | — | $-0.00 | — | |
2022-12-31 FY2022 | — | $-0.00 | — | |
2021-12-31 FY2021 | — | $-0.00 | — | |
2020-12-31 FY2020 | — | $-0.00 | — | |
2019-12-31 FY2019 | — | $-0.00 | — | |
2018-12-31 FY2018 | — | $0.00 | — | |
2017-12-31 FY2017 | — | $-0.00 | — | |
2016-12-31 FY2016 | — | $-0.00 | — | |
2015-12-31 FY2015 | — | $-0.01 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for BioTech Medics, Inc. (BMCS) measures how much investors pay for each dollar of the company's trailing earnings. BMCS's current PE ratio of 1.24x is calculated by dividing its stock price of $0.00 by its TTM earnings per share of $0.00.
Frequently asked questions
BMCS pe ratio · 6 questionsBMCS's current PE ratio is 1.24x as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of $0.00. Data sourced from Financial Modeling Prep via BMCS's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · BioTech Medics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09